Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CETUXIMAB for Neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 16 adverse event reports in the FDA FAERS database where CETUXIMAB was used for Neoplasm.

Most Reported Side Effects for CETUXIMAB

Side Effect Reports % Deaths Hosp.
Off label use 1,549 10.6% 234 514
Rash 883 6.1% 61 145
Diarrhoea 874 6.0% 123 434
Neutropenia 744 5.1% 88 137
Nausea 663 4.6% 50 284
Malignant neoplasm progression 662 4.6% 225 172
Dyspnoea 542 3.7% 55 225
Decreased appetite 541 3.7% 75 255
Vomiting 533 3.7% 63 293
Death 518 3.6% 518 69
Anaemia 508 3.5% 69 177
Myelosuppression 493 3.4% 4 317
Pyrexia 477 3.3% 62 298
Fatigue 463 3.2% 65 158
White blood cell count decreased 463 3.2% 22 182

Other Indications for CETUXIMAB

Colorectal cancer metastatic (1,960) Colon cancer (1,522) Product used for unknown indication (1,369) Squamous cell carcinoma of head and neck (1,130) Colorectal cancer (909) Head and neck cancer (885) Colon cancer metastatic (553) Rectal cancer (542) Adenocarcinoma of colon (469) Squamous cell carcinoma (283)

Other Drugs Used for Neoplasm

BEVACIZUMAB (502) ATEZOLIZUMAB (404) CYCLOPHOSPHAMIDE (385) CARBOPLATIN (283) PACLITAXEL (267) NIVOLUMAB (219) OXALIPLATIN (185) PEMBROLIZUMAB (173) LENALIDOMIDE (171) DOXORUBICIN (150)

Related Pages

CETUXIMAB Full Profile All Neoplasm Drugs CETUXIMAB Demographics CETUXIMAB Timeline